Priser
Platform
Blog
Om os
Download
RHOEN-KLINIKUM
RHOEN-KLINIKUM
Deutsche Börse Xetra
0

Om

Rhoen-Klinikum AG operates as a prominent healthcare provider primarily in Germany. It focuses on delivering high-quality medical services through a comprehensive network of hospitals and healthcare facilities. As one of the largest groups within the German medical landscape, Rhoen-Klinikum AG plays a crucial role in advancing patient care and medical innovation. The company is renowned for offering a wide array of medical disciplines, including surgery, internal medicine, cardiology, and orthopedics, thus catering to diverse healthcare needs. Rhoen-Klinikum AG also prioritizes the integration of cutting-edge medical technologies and practices to enhance treatment outcomes. By serving various communities across Germany, the organization significantly contributes to the nation's healthcare system, ensuring accessibility and excellence in medical services. Its position in the market underscores the vital role of healthcare providers in supporting public health infrastructure and addressing the evolving demands of medical advancements and patient care.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I RHOEN-KLINIKUM MED ENDAVU: Køb RHOEN-KLINIKUM ($RHK) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i RHOEN-KLINIKUM, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerRHK
Land
Tyskland
Antal medarbejdere18.821
Hjemmesiderhoen-klinikum-ag.com
SektorSundhed
IndustriMedicinske plejefaciliteter

Udbytter

0,8EUR
'16
0,35EUR
'17
0,22EUR
'18
0,29EUR
'19
0,15EUR
'23
0,1EUR
'25
Ex-udbytte-dato4. jun. 2025
Udbytteafkast0,85%

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
0%0%100%0%0%